Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

WASHINGTON, Jan 21 (Reuters) - After two years of progress on inflation and surprisingly persistent economic growth, the Federal Reserve next week meets with one eye on new Trump administration ...

As this new reality has sunk in, the bond market has changed its expectations dramatically, said David Krause, professor of finance emeritus at Marquette University. “The Federal Reserve ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.